Evidence map›Paper›PMID 37341394›Full record

ArticleeLife2023

Complex subsets but redundant clonality after B cells egress from spontaneous germinal centers.

Carlos Castrillon, Lea Simoni, Theo van den Broek, Cees van der Poel, Elliot H Akama-Garren, Minghe Ma, Michael C Carroll

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. TACI regulates marginal zone B cell development.The Journal of experimental medicine · 2026
    Article
  2. Review
  3. Article
  4. T cell help shapes B cell tolerance.Science immunology · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Carlos CastrillonProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States.ORCID 0000-0003-2909-7371
Lea Simoni *Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States.
Theo van den Broek *Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States.ORCID 0000-0002-2781-5731
Cees van der Poel *Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States.
Elliot H Akama-GarrenProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States.ORCID 0000-0002-1690-2055
Minghe MaProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States.ORCID 0000-0002-4496-6240
Michael C CarrollProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States.ORCID 0000-0002-3213-4295
Boston University · USBoston Children's Hospital · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
TRAINING IN TRANSPLANTATION BIOLOGYT32AI007529 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1998 to 2024
$6.4M
Evolution of autoreactive GC and epitope spreading in lupusR01AR074105 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI Michael Craig Carroll · 2018 to 2026
$4.2M
FDC regulation of self-reactive B cellsR01AI130307 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI CARROLL, MICHAEL CRAIG · 2018 to 2022
$2.7M
Follicular helper T cells as drivers of epitope spreadingF30AI160909 · NIAID · HARVARD MEDICAL SCHOOL · PI AKAMA-GARREN, ELLIOT HIDEKI · 2021 to 2023
$125k
NIAID NIH HHS F30 AI160909NIAID NIH HHS R01 AI130307NIAID NIH HHS T32 AI007529NIAMS NIH HHS R01 AR074105NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32 GM144273NIH HHS F30AI160909NIH HHS R01AI130307NIH HHS R01AR074105NIH HHS T32AI007529NIH HHS T32GM007753
6 · The paper itself

Abstract

Affinity matured self-reactive antibodies are found in autoimmune diseases like systemic lupus erythematous. Here, we used fate-mapping reporter mice and single-cell transcriptomics coupled to antibody repertoire analysis to characterize the post-germinal center (GC) B cell compartment in a new mouse model of autoimmunity. Antibody-secreting cells (ASCs) and memory B cells (MemBs) from spontaneous GCs grouped into multiple subclusters. ASCs matured into two terminal clusters, with distinct secretion, antibody repertoire and metabolic profiles. MemBs contained FCRL5+ and CD23+ subsets, with different in vivo localization in the spleen. GC-derived FCRL5+ MemBs share transcriptomic and repertoire properties with atypical B cells found in aging and infection and localize to the marginal zone, suggesting a similar contribution to recall responses. While transcriptomically diverse, ASC and MemB subsets maintained an underlying clonal redundancy. Therefore, self-reactive clones could escape subset-targeting therapy by perpetuation of self-reactivity in distinct subsets.

Indexed as

Autoimmune DiseasesB-LymphocytesAnimalsAutoantibodiesAutoimmunityGerminal CenterMiceAutoantibodiesantibody-secreting cellautoimmunityB cell receptor repertoireimmunologyinflammationmemory B cellmousesingle-cell sequencing

Identifiers

PMID37341394
PMCPMC10351918
OpenAlexW4381470549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.